Assetmark, Inc Teva Pharmaceutical Industries LTD Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Assetmark, Inc holds 354 shares of TEVA stock, worth $5,816. This represents 0.0% of its overall portfolio holdings.

Number of Shares

354

Previous 546 35.16%

Holding current value

$5,816

Previous $8,000 25.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$15.81 - $18.96 $3,035 - $3,640	-192 Reduced 35.16%	354 $6,000
Q2 2024 Aug 13, 2024	BUY	$12.78 - $17.4 $6,977 - $9,500	546 New	546 $8,000
Q3 2019 Nov 13, 2019	SELL	$6.16 - $9.6 $9,313 - $14,515	-1,512 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $292 - $565	-36 Reduced 2.33%	1,512 $14,000
Q1 2019 May 14, 2019	SELL	$15.58 - $20.01 $1,558 - $2,001	-100 Reduced 6.07%	1,548 $24,000
Q4 2018 Feb 13, 2019	SELL	$14.59 - $23.84 $11,672 - $19,072	-800 Reduced 32.68%	1,648 $25,000
Q3 2018 Nov 13, 2018	SELL	$21.06 - $25.65 $2,527 - $3,078	-120 Reduced 4.67%	2,448 $53,000
Q2 2018 Aug 01, 2018	BUY	$16.77 - $24.71 $15,998 - $23,573	954 Added 59.11%	2,568 $62,000
Q1 2018 May 16, 2018	SELL	$16.68 - $22.07 $4,953 - $6,554	-297 Reduced 15.54%	1,614 $28,000
Q4 2017 Feb 13, 2018	SELL	$11.23 - $19.1 $718 - $1,222	-64 Reduced 3.24%	1,911 $36,000
Q3 2017 Nov 08, 2017	SELL	$15.41 - $32.17 $15,394 - $32,137	-999 Reduced 33.59%	1,975 $35,000
Q2 2017 Aug 15, 2017	BUY	N/A	1,020 Added 52.2%	2,974 $99,000
Q1 2017 Sep 15, 2017	SELL	N/A	-2,173 Reduced 52.65%	1,954 $63,000
Q4 2016 Sep 15, 2017	SELL	N/A	-1,072 Reduced 20.62%	4,127 $150,000
Q3 2016 Sep 15, 2017	SELL	N/A	-595 Reduced 10.27%	5,199 $239,000
Q2 2016 Sep 15, 2017	BUY	N/A	719 Added 14.17%	5,794 $291,000
Q1 2016 Sep 15, 2017	SELL	N/A	-26,669 Reduced 84.01%	5,075 $272,000
Q4 2015 Sep 15, 2017	BUY	N/A	31,744	31,744 $2.08 Million

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.2B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account